Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.


Department of Radiation Oncology, University of Rochester, Rochester, NY. Electronic address: [Email]


Metastatic prostate cancer (MPC) prognosis is variable. Few population-based studies have examined the impact of particular visceral metastatic sites on MPC survival outcomes. We investigated this using the Surveillance, Epidemiology, and End Results (SEER) database.


Bone-only metastases,Lung metastases,Oligometastatic,Prognosis,SEER,